Sugiyama Gen, Okabe Yoshinobu, Ishida Yusuke, Saitou Fumihiko, Kawahara Ryuichi, Ishikawa Hiroto, Horiuchi Hiroyuki, Kinoshita Hisafumi, Tsuruta Osamu, Sata Michio
Gen Sugiyama, Yoshinobu Okabe, Yusuke Ishida, Fumihiko Saitou, Ryuichi Kawahara, Hiroto Ishikawa, Hiroyuki Horiuchi, Hisafumi Kinoshita, Osamu Tsuruta, Michio Sata, Division of Gastroenterology, Department of Medicine, Kurume University School of Medicine, Kurume 830-0011, Japan.
World J Gastroenterol. 2014 Jun 14;20(22):6968-73. doi: 10.3748/wjg.v20.i22.6968.
To review the usefulness of endoscopic biliary stenting for obstructive jaundice caused by hepatocellular carcinoma and identify problems that may need to be addressed.
The study population consisted of 36 patients with obstructive jaundice caused by hepatocellular carcinoma (HCC) who underwent endoscopic biliary stenting (EBS) as the initial drainage procedure at our hospital. The EBS technical success rate and drainage success rate were assessed. Drainage was considered effective when the serum total bilirubin level decreased by 50% or more following the procedure compared to the pre-drainage value. Survival time after the procedure and patient background characteristics were assessed comparatively between the successful drainage group (group A) and the non-successful drainage group (group B). The EBS stent patency duration in the successful drainage group (group A) was also assessed.
The technical success rate was 100% for both the initial endoscopic nasobiliary drainage and EBS in all patients. Single stenting was placed in 21 patients and multiple stenting in the remaining 15 patients. The drainage successful rate was 75% and the median interval to successful drainage was 40 d (2-295 d). The median survival time was 150 d in group A and 22 d in group B, with the difference between the two groups being statistically significant (P < 0.0001). There were no statistically significant differences between the two groups with respect to patient background characteristics, background liver condition, or tumor factors; on the other hand, the two groups showed statistically significant differences in patients without a history of hepatectomy (P = 0.009) and those that received multiple stenting (P = 0.036). The median duration of stent patency was 43 d in group A (2-757 d). No early complications related to the EBS technique were encountered. Late complications occurred in 13 patients (36.1%), including stent occlusion in 7, infection in 3, and distal migration in 3.
EBS is recommended as the initial drainage procedure for obstructive jaundice caused by HCC, as it appears to contribute to prolongation of survival time.
回顾内镜下胆道支架置入术对肝细胞癌所致梗阻性黄疸的有效性,并确定可能需要解决的问题。
研究对象为36例因肝细胞癌(HCC)导致梗阻性黄疸的患者,他们在我院接受内镜下胆道支架置入术(EBS)作为初始引流程序。评估EBS技术成功率和引流成功率。若术后血清总胆红素水平较引流前降低50%或更多,则认为引流有效。比较成功引流组(A组)和未成功引流组(B组)术后生存时间及患者背景特征。还评估了成功引流组(A组)的EBS支架通畅持续时间。
所有患者初次内镜鼻胆管引流和EBS的技术成功率均为100%。21例患者置入单个支架,其余15例患者置入多个支架。引流成功率为75%,成功引流的中位间隔时间为40天(2 - 295天)。A组中位生存时间为150天,B组为22天,两组间差异有统计学意义(P < 0.0001)。两组在患者背景特征、基础肝脏状况或肿瘤因素方面无统计学显著差异;另一方面,两组在无肝切除史的患者(P = 0.009)和接受多个支架置入的患者(P = 0.036)中显示出统计学显著差异。A组支架通畅的中位持续时间为43天(2 - 757天)。未遇到与EBS技术相关的早期并发症。13例患者(36.1%)发生晚期并发症,包括7例支架阻塞、3例感染和3例远端移位。
EBS推荐作为HCC所致梗阻性黄疸的初始引流程序,因为它似乎有助于延长生存时间。